{
    "answer": "2024 Full Year Immunology Segment Net Sales: USD 53.7 billion (+12% reported, +12% CC)\n2023 Full Year Immunology Segment Net Sales: USD 45.4 billion (+8% reported, +10% CC)\nThe reported immunology segment net sales in full year 2024 were 12% higher than in full year 2023, and the results are the same on both a reported and constant currency basis compared to 2023.\nCosentyx's net sales in the immunology segment for the full year 2024 were USD 53.7 billion, showing a 12% increase compared to the full year 2023 (USD 45.4 billion, a 10% increase), both on a reported and constant currency basis.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        935,
        2494,
        4303,
        5693,
        7577
    ]
}